MassiveID	filename	SampleType	SampleTypeSub1	NCBITaxonomy	YearOfAnalysis	SampleCollectionMethod	SampleExtractionMethod	InternalStandardsUsed	MassSpectrometer	IonizationSourceAndPolarity	ChromatographyAndPhase	SubjectIdentifierAsRecorded	AgeInYears	BiologicalSex	UBERONBodyPartName	TermsofPosition	HealthStatus	DOIDCommonName	ComorbidityListDOIDIndex	SampleCollectionDateandTime	Country	HumanPopulationDensity	LatitudeandLongitude	DepthorAltitudeMeters	qiita_sample_name	UniqueSubjectID	LifeStage	UBERONOntologyIndex	DOIDOntologyIndex
MSV000085724	Plate_Blank_01_GA1_01_54891.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_01	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.25	not collected	Metabolomics_Plate_Blank_01	MSV000085724_Plate_Blank_01	not applicable	not applicable	not applicable
MSV000085724	Plate_Blank_02_GB1_01_54906.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_02	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.26	not collected	Metabolomics_Plate_Blank_02	MSV000085724_Plate_Blank_02	not applicable	not applicable	not applicable
MSV000085724	Plate_Blank_03_GC1_01_54920.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_03	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.27	not collected	Metabolomics_Plate_Blank_03	MSV000085724_Plate_Blank_03	not applicable	not applicable	not applicable
MSV000085724	Plate_Blank_04_GD1_01_54935.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_04	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.28	not collected	Metabolomics_Plate_Blank_04	MSV000085724_Plate_Blank_04	not applicable	not applicable	not applicable
MSV000085724	Plate_Blank_06_GF1_01_54967.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_06	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.29	not collected	Metabolomics_Plate_Blank_06	MSV000085724_Plate_Blank_06	not applicable	not applicable	not applicable
MSV000085724	Plate_Blank_07_GG1_01_54983.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_07	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.30	not collected	Metabolomics_Plate_Blank_07	MSV000085724_Plate_Blank_07	not applicable	not applicable	not applicable
MSV000085724	Plate_Blank_08_GH1_01_55000.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_08	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.31	not collected	Metabolomics_Plate_Blank_08	MSV000085724_Plate_Blank_08	not applicable	not applicable	not applicable
MSV000085724	Plate_Blank_09_GA1_01_55018.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_09	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.32	not collected	Metabolomics_Plate_Blank_09	MSV000085724_Plate_Blank_09	not applicable	not applicable	not applicable
MSV000085724	Plate_Blank_10_GB1_01_55034.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_10	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.33	not collected	Metabolomics_Plate_Blank_10	MSV000085724_Plate_Blank_10	not applicable	not applicable	not applicable
MSV000085724	Plate_Blank_11_GC1_01_55050.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_11	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.34	not collected	Metabolomics_Plate_Blank_11	MSV000085724_Plate_Blank_11	not applicable	not applicable	not applicable
MSV000085724	Plate_Blank_12_GD1_01_55066.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_12	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.35	not collected	Metabolomics_Plate_Blank_12	MSV000085724_Plate_Blank_12	not applicable	not applicable	not applicable
MSV000085724	Plate_Blank_13_GE1_01_55084.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_13	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.36	not collected	Metabolomics_Plate_Blank_13	MSV000085724_Plate_Blank_13	not applicable	not applicable	not applicable
MSV000085724	Plate_Blank_14_GF1_01_55100.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_14	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.37	not collected	Metabolomics_Plate_Blank_14	MSV000085724_Plate_Blank_14	not applicable	not applicable	not applicable
MSV000085724	Plate_Blank_15_GG1_01_55116.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_15	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.38	not collected	Metabolomics_Plate_Blank_15	MSV000085724_Plate_Blank_15	not applicable	not applicable	not applicable
MSV000085724	Plate_Blank_16_GH1_01_55133.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_16	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.39	not collected	Metabolomics_Plate_Blank_16	MSV000085724_Plate_Blank_16	not applicable	not applicable	not applicable
MSV000085724	Plate_Blank_18_GG1_01_55158.mzXML	blank_extraction	blank_extraction	not applicable	2020	liquid	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	Plate_Blank_18	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	not applicable	6/16/20	United States of America	Urban	32.5|-117.40	not collected	Metabolomics_Plate_Blank_18	MSV000085724_Plate_Blank_18	not applicable	not applicable	not applicable
MSV000085724	X2036767_GC3_01_54922.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2036767	46	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	7/1/09	United States of America	Urban	32.5|-117.41	not collected	12667.X2036767	MSV000085724_X2036767	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2036793_GF3_01_54969.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2036793	51	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	7/1/09	United States of America	Urban	32.5|-117.42	not collected	12667.X2036793	MSV000085724_X2036793	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2037715_GC2_01_54921.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2037715	54	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	5/6/09	United States of America	Urban	32.5|-117.43	not collected	12667.X2037715	MSV000085724_X2037715	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2041787_GA9_01_54899.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2041787	20	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	7/7/08	United States of America	Urban	32.5|-117.44	not collected	12667.X2041787	MSV000085724_X2041787	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2043129_rerun_GG4_01_55162.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2043129	62	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	4/28/09	United States of America	Urban	32.5|-117.45	not collected	12667.X2043129	MSV000085724_X2043129	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2043400_GD2_01_54936.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2043400	36	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	2/20/09	United States of America	Urban	32.5|-117.46	not collected	12667.X2043400	MSV000085724_X2043400	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2044156_GH9_01_55009.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2044156	50	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	8/22/08	United States of America	Urban	32.5|-117.47	not collected	12667.X2044156	MSV000085724_X2044156	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2047268_GE7_01_54959.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2047268	47	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	10/2/10	United States of America	Urban	32.5|-117.48	not collected	12667.X2047268	MSV000085724_X2047268	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2048152_GB10_01_54915.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2048152	47	female	blood plasma	not applicable	Healthy	no disease reported	no disease reported	12/15/09	United States of America	Urban	32.5|-117.49	not collected	12667.X2048152	MSV000085724_X2048152	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2049520_GD8_01_54943.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2049520	53	female	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	1/8/08	United States of America	Urban	32.5|-117.50	not collected	12667.X2049520	MSV000085724_X2049520	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2050079_GH6_01_55005.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2050079	62	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	11/28/07	United States of America	Urban	32.5|-117.51	not collected	12667.X2050079	MSV000085724_X2050079	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2050331_GD5_01_54939.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2050331	60	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	6/7/09	United States of America	Urban	32.5|-117.52	not collected	12667.X2050331	MSV000085724_X2050331	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2051123_rerun_GG10_01_55169.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2051123	59	female	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	1/28/09	United States of America	Urban	32.5|-117.53	not collected	12667.X2051123	MSV000085724_X2051123	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2051138_GC6_01_54925.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2051138	26	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	1/27/09	United States of America	Urban	32.5|-117.54	not collected	12667.X2051138	MSV000085724_X2051138	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2051273_GC7_01_54927.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2051273	37	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	4/9/08	United States of America	Urban	32.5|-117.55	not collected	12667.X2051273	MSV000085724_X2051273	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2052566_GC5_01_54924.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2052566	61	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	9/15/08	United States of America	Urban	32.5|-117.56	not collected	12667.X2052566	MSV000085724_X2052566	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2052632_GE2_01_54953.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2052632	36	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	9/19/08	United States of America	Urban	32.5|-117.57	not collected	12667.X2052632	MSV000085724_X2052632	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2052835_GF8_01_54976.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2052835	49	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	9/18/08	United States of America	Urban	32.5|-117.58	not collected	12667.X2052835	MSV000085724_X2052835	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2055743_rerun_GG3_01_55161.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2055743	42	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	2/13/09	United States of America	Urban	32.5|-117.59	not collected	12667.X2055743	MSV000085724_X2055743	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2055755_GE9_01_54961.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2055755	54	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	1/23/09	United States of America	Urban	32.5|-117.60	not collected	12667.X2055755	MSV000085724_X2055755	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2055863_GE3_01_54954.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2055863	55	female	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	9/6/09	United States of America	Urban	32.5|-117.61	not collected	12667.X2055863	MSV000085724_X2055863	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2056691_GB3_01_54908.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2056691	40	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	5/15/08	United States of America	Urban	32.5|-117.62	not collected	12667.X2056691	MSV000085724_X2056691	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2058630_GH10_01_55010.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2058630	50	female	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	5/21/08	United States of America	Urban	32.5|-117.63	not collected	12667.X2058630	MSV000085724_X2058630	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2058733_GE5_01_54956.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2058733	26	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	7/3/08	United States of America	Urban	32.5|-117.64	not collected	12667.X2058733	MSV000085724_X2058733	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2059586_GA11_01_54901.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2059586	43	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	4/17/08	United States of America	Urban	32.5|-117.65	not collected	12667.X2059586	MSV000085724_X2059586	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2059598_GE11_01_54963.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2059598	42	female	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	4/23/08	United States of America	Urban	32.5|-117.66	not collected	12667.X2059598	MSV000085724_X2059598	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2060511_GB11_01_54916.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2060511	53	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	3/21/08	United States of America	Urban	32.5|-117.67	not collected	12667.X2060511	MSV000085724_X2060511	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2060655_GF9_01_54977.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2060655	39	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	3/14/08	United States of America	Urban	32.5|-117.68	not collected	12667.X2060655	MSV000085724_X2060655	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2060824_GA10_01_54900.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2060824	30	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	3/4/08	United States of America	Urban	32.5|-117.69	not collected	12667.X2060824	MSV000085724_X2060824	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2060998_GC10_01_54930.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2060998	31	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	8/1/08	United States of America	Urban	32.5|-117.70	not collected	12667.X2060998	MSV000085724_X2060998	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2061208_GF7_01_54975.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2061208	66	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	1/17/08	United States of America	Urban	32.5|-117.71	not collected	12667.X2061208	MSV000085724_X2061208	Later Adulthood (>65 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2061316_GA7_01_54897.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2061316	46	female	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	1/31/08	United States of America	Urban	32.5|-117.72	not collected	12667.X2061316	MSV000085724_X2061316	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2061359_GF2_01_54968.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2061359	34	female	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	1/24/08	United States of America	Urban	32.5|-117.73	not collected	12667.X2061359	MSV000085724_X2061359	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2061574_RF11_01_55112.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2061574	61	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	10/17/07	United States of America	Urban	32.5|-117.74	not collected	12667.X2061574	MSV000085724_X2061574	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2062455_GF11_01_54979.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2062455	46	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	7/2/08	United States of America	Urban	32.5|-117.75	not collected	12667.X2062455	MSV000085724_X2062455	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2062504_rerun_GG6_01_55164.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2062504	43	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	2/21/08	United States of America	Urban	32.5|-117.76	not collected	12667.X2062504	MSV000085724_X2062504	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2062564_rerun_GG2_01_55160.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2062564	56	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	2/22/08	United States of America	Urban	32.5|-117.77	not collected	12667.X2062564	MSV000085724_X2062564	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2062715_GH7_01_55007.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2062715	58	female	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	12/10/07	United States of America	Urban	32.5|-117.78	not collected	12667.X2062715	MSV000085724_X2062715	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2062809_GA4_01_54894.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2062809	44	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	11/13/07	United States of America	Urban	32.5|-117.79	not collected	12667.X2062809	MSV000085724_X2062809	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2062843_GH5_01_55004.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2062843	49	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	10/31/07	United States of America	Urban	32.5|-117.80	not collected	12667.X2062843	MSV000085724_X2062843	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2062861_GD11_01_54946.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2062861	64	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	6/11/07	United States of America	Urban	32.5|-117.81	not collected	12667.X2062861	MSV000085724_X2062861	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2062971_RB7_01_55042.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2062971	30	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	10/26/07	United States of America	Urban	32.5|-117.82	not collected	12667.X2062971	MSV000085724_X2062971	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2064352_RF6_01_55106.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2064352	60	female	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	8/11/07	United States of America	Urban	32.5|-117.83	not collected	12667.X2064352	MSV000085724_X2064352	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2064365_rerun_GG5_01_55163.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2064365	45	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	11/16/07	United States of America	Urban	32.5|-117.84	not collected	12667.X2064365	MSV000085724_X2064365	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2064367_RG6_01_55122.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2064367	42	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	11/16/07	United States of America	Urban	32.5|-117.85	not collected	12667.X2064367	MSV000085724_X2064367	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2064759_RG11_01_55129.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2064759	56	female	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	8/13/07	United States of America	Urban	32.5|-117.86	not collected	12667.X2064759	MSV000085724_X2064759	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2064845_GB9_01_54914.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2064845	51	female	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	9/19/07	United States of America	Urban	32.5|-117.87	not collected	12667.X2064845	MSV000085724_X2064845	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2065050_GD3_01_54937.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2065050	40	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	7/31/07	United States of America	Urban	32.5|-117.88	not collected	12667.X2065050	MSV000085724_X2065050	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2065210_RF10_01_55111.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2065210	49	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	8/30/07	United States of America	Urban	32.5|-117.89	not collected	12667.X2065210	MSV000085724_X2065210	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2066035_GB4_01_54909.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2066035	36	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	9/14/07	United States of America	Urban	32.5|-117.90	not collected	12667.X2066035	MSV000085724_X2066035	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2066114_rerun_GG11_01_55170.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2066114	58	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	10/9/07	United States of America	Urban	32.5|-117.91	not collected	12667.X2066114	MSV000085724_X2066114	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2066293_GE4_01_54955.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2066293	47	female	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	9/10/07	United States of America	Urban	32.5|-117.92	not collected	12667.X2066293	MSV000085724_X2066293	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2067131_RC7_01_55058.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2067131	54	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	9/29/07	United States of America	Urban	32.5|-117.93	not collected	12667.X2067131	MSV000085724_X2067131	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2067157_GH4_01_55003.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2067157	44	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	11/13/07	United States of America	Urban	32.5|-117.94	not collected	12667.X2067157	MSV000085724_X2067157	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2068135_GF6_01_54973.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2068135	39	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	4/17/07	United States of America	Urban	32.5|-117.95	not collected	12667.X2068135	MSV000085724_X2068135	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2068559_GH3_01_55002.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2068559	32	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	1/26/10	United States of America	Urban	32.5|-117.96	not collected	12667.X2068559	MSV000085724_X2068559	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2068760_RB4_01_55038.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2068760	68	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	4/30/07	United States of America	Urban	32.5|-117.97	not collected	12667.X2068760	MSV000085724_X2068760	Later Adulthood (>65 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2068905_rerun_GA5_01_55153.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2068905	47	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	12/4/07	United States of America	Urban	32.5|-117.98	not collected	12667.X2068905	MSV000085724_X2068905	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2068928_GC9_01_54929.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2068928	45	female	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	11/4/07	United States of America	Urban	32.5|-117.99	not collected	12667.X2068928	MSV000085724_X2068928	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2068956_GF10_01_54978.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2068956	50	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	4/13/07	United States of America	Urban	32.5|-117.100	not collected	12667.X2068956	MSV000085724_X2068956	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2068980_GF12_01_54980.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2068980	59	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	3/26/07	United States of America	Urban	32.5|-117.101	not collected	12667.X2068980	MSV000085724_X2068980	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2069204_GF4_01_54972.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2069204	61	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	3/29/07	United States of America	Urban	32.5|-117.102	not collected	12667.X2069204	MSV000085724_X2069204	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2069208_GC11_01_54931.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2069208	51	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	3/22/07	United States of America	Urban	32.5|-117.103	not collected	12667.X2069208	MSV000085724_X2069208	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2069281_RE1_01_55085.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2069281	50	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	4/4/07	United States of America	Urban	32.5|-117.104	not collected	12667.X2069281	MSV000085724_X2069281	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2069618_RG4_01_55120.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2069618	56	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	10/4/07	United States of America	Urban	32.5|-117.105	not collected	12667.X2069618	MSV000085724_X2069618	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2070271_GB2_01_54907.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2070271	51	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	2/3/10	United States of America	Urban	32.5|-117.106	not collected	12667.X2070271	MSV000085724_X2070271	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2070621_GB8_01_54913.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2070621	51	female	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526	7/24/07	United States of America	Urban	32.5|-117.107	not collected	12667.X2070621	MSV000085724_X2070621	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2070791_GH2_01_55001.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2070791	40	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	5/25/07	United States of America	Urban	32.5|-117.108	not collected	12667.X2070791	MSV000085724_X2070791	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2070873_GC8_01_54928.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2070873	60	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	6/25/07	United States of America	Urban	32.5|-117.109	not collected	12667.X2070873	MSV000085724_X2070873	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2071659_GD6_01_54940.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2071659	49	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	3/31/10	United States of America	Urban	32.5|-117.110	not collected	12667.X2071659	MSV000085724_X2071659	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2071711_GD7_01_54941.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2071711	25	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	8/4/10	United States of America	Urban	32.5|-117.111	not collected	12667.X2071711	MSV000085724_X2071711	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2073293_RC6_01_55056.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2073293	54	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	5/14/07	United States of America	Urban	32.5|-117.112	not collected	12667.X2073293	MSV000085724_X2073293	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2073298_RB5_01_55039.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2073298	58	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	5/15/07	United States of America	Urban	32.5|-117.113	not collected	12667.X2073298	MSV000085724_X2073298	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2073324_rerun_GB6_01_55154.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2073324	52	female	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	9/5/07	United States of America	Urban	32.5|-117.114	not collected	12667.X2073324	MSV000085724_X2073324	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2074003_GE8_01_54960.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2074003	55	female	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	5/25/07	United States of America	Urban	32.5|-117.115	not collected	12667.X2074003	MSV000085724_X2074003	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2076870_RD4_01_55070.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2076870	47	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	12/3/10	United States of America	Urban	32.5|-117.116	not collected	12667.X2076870	MSV000085724_X2076870	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2076954_RD3_01_55069.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2076954	31	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	3/15/10	United States of America	Urban	32.5|-117.117	not collected	12667.X2076954	MSV000085724_X2076954	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2076970_RG5_01_55121.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2076970	51	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	3/15/10	United States of America	Urban	32.5|-117.118	not collected	12667.X2076970	MSV000085724_X2076970	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2105130_RD5_01_55071.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2105130	49	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	3/22/07	United States of America	Urban	32.5|-117.119	not collected	12667.X2105130	MSV000085724_X2105130	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2109273_GE12_01_54964.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2109273	44	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	10/8/07	United States of America	Urban	32.5|-117.120	not collected	12667.X2109273	MSV000085724_X2109273	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2130028_RF1_01_55101.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2130028	38	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	6/8/10	United States of America	Urban	32.5|-117.121	not collected	12667.X2130028	MSV000085724_X2130028	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2147547_RC3_01_55053.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2147547	29	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	8/28/10	United States of America	Urban	32.5|-117.122	not collected	12667.X2147547	MSV000085724_X2147547	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2170593_RD10_01_55077.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2170593	52	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	11/18/10	United States of America	Urban	32.5|-117.123	not collected	12667.X2170593	MSV000085724_X2170593	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	no disease reported
MSV000085724	X2171346_RH5_01_55138.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2171346	24	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	8/10/10	United States of America	Urban	32.5|-117.124	not collected	12667.X2171346	MSV000085724_X2171346	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2330723_RB6_01_55040.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2330723	36	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	10/2/11	United States of America	Urban	32.5|-117.125	not collected	12667.X2330723	MSV000085724_X2330723	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2339235_GC4_01_54923.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2339235	25	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	5/23/11	United States of America	Urban	32.5|-117.126	not collected	12667.X2339235	MSV000085724_X2339235	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2342267_RF5_01_55105.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2342267	24	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	4/2/11	United States of America	Urban	32.5|-117.127	not collected	12667.X2342267	MSV000085724_X2342267	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2342424_RB2_01_55036.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2342424	58	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	1/25/11	United States of America	Urban	32.5|-117.128	not collected	12667.X2342424	MSV000085724_X2342424	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2378267_RE5_01_55089.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2378267	46	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	5/27/11	United States of America	Urban	32.5|-117.129	not collected	12667.X2378267	MSV000085724_X2378267	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2392039_RG2_01_55118.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2392039	51	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	4/4/11	United States of America	Urban	32.5|-117.130	not collected	12667.X2392039	MSV000085724_X2392039	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2403373_RA2_01_55020.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2403373	30	female	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	10/9/11	United States of America	Urban	32.5|-117.131	not collected	12667.X2403373	MSV000085724_X2403373	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2403412_RE10_01_55095.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2403412	63	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	11/29/11	United States of America	Urban	32.5|-117.132	not collected	12667.X2403412	MSV000085724_X2403412	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2450452_rerun_GG8_01_55167.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2450452	43	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	9/19/13	United States of America	Urban	32.5|-117.133	not collected	12667.X2450452	MSV000085724_X2450452	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2454540_GE10_01_54962.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2454540	54	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	12/16/11	United States of America	Urban	32.5|-117.134	not collected	12667.X2454540	MSV000085724_X2454540	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2454595_RF3_01_55103.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2454595	44	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	1/12/11	United States of America	Urban	32.5|-117.135	not collected	12667.X2454595	MSV000085724_X2454595	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2454843_RC10_01_55061.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2454843	34	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	11/30/11	United States of America	Urban	32.5|-117.136	not collected	12667.X2454843	MSV000085724_X2454843	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2454883_GA6_01_54896.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2454883	40	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	2/12/11	United States of America	Urban	32.5|-117.137	not collected	12667.X2454883	MSV000085724_X2454883	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2457964_RH10_01_55144.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2457964	36	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	1/21/12	United States of America	Urban	32.5|-117.138	not collected	12667.X2457964	MSV000085724_X2457964	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2470952_RG1_01_55117.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2470952	25	female	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	8/6/12	United States of America	Urban	32.5|-117.139	not collected	12667.X2470952	MSV000085724_X2470952	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2471017_RB8_01_55043.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2471017	62	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	5/22/12	United States of America	Urban	32.5|-117.140	not collected	12667.X2471017	MSV000085724_X2471017	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2471544_RE2_01_55086.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2471544	42	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	8/6/12	United States of America	Urban	32.5|-117.141	not collected	12667.X2471544	MSV000085724_X2471544	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2472337_RE12_01_55097.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2472337	50	female	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	8/22/12	United States of America	Urban	32.5|-117.142	not collected	12667.X2472337	MSV000085724_X2472337	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2472497_GB12_01_54917.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2472497	51	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	8/13/12	United States of America	Urban	32.5|-117.143	not collected	12667.X2472497	MSV000085724_X2472497	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2480300_rerun_GB7_01_55155.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2480300	68	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	no disease reported	7/31/12	United States of America	Urban	32.5|-117.144	not collected	12667.X2480300	MSV000085724_X2480300	Later Adulthood (>65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2483184_RG7_01_55125.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2483184	48	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	1/12/12	United States of America	Urban	32.5|-117.145	not collected	12667.X2483184	MSV000085724_X2483184	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2487909_RH3_01_55136.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2487909	49	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	10/9/12	United States of America	Urban	32.5|-117.146	not collected	12667.X2487909	MSV000085724_X2487909	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2488000_RF7_01_55108.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2488000	40	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	9/14/12	United States of America	Urban	32.5|-117.147	not collected	12667.X2488000	MSV000085724_X2488000	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2488349_RA3_01_55021.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2488349	31	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	10/24/12	United States of America	Urban	32.5|-117.148	not collected	12667.X2488349	MSV000085724_X2488349	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2488384_RD2_01_55068.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2488384	51	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	5/10/12	United States of America	Urban	32.5|-117.149	not collected	12667.X2488384	MSV000085724_X2488384	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2489136_GC12_01_54932.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2489136	26	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	11/17/12	United States of America	Urban	32.5|-117.150	not collected	12667.X2489136	MSV000085724_X2489136	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X2490051_RE3_01_55087.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2490051	50	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	1/10/12	United States of America	Urban	32.5|-117.151	not collected	12667.X2490051	MSV000085724_X2490051	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2491176_RH4_01_55137.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2491176	52	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	10/31/12	United States of America	Urban	32.5|-117.152	not collected	12667.X2491176	MSV000085724_X2491176	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X2493385_rerun_RC4_01_55173.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2493385	46	female	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	2/25/13	United States of America	Urban	32.5|-117.153	not collected	12667.X2493385	MSV000085724_X2493385	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X2496221_RB11_01_55046.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X2496221	41	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	11/1/13	United States of America	Urban	32.5|-117.154	not collected	12667.X2496221	MSV000085724_X2496221	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	no disease reported
MSV000085724	X3001839_RD12_01_55079.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3001839	62	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	12/3/13	United States of America	Urban	32.5|-117.155	not collected	12667.X3001839	MSV000085724_X3001839	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3003105_RG10_01_55128.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3003105	26	female	blood plasma	not applicable	Healthy	no disease reported	no disease reported	2/5/13	United States of America	Urban	32.5|-117.156	not collected	12667.X3003105	MSV000085724_X3003105	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	no disease reported
MSV000085724	X3004746_RB3_01_55037.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3004746	30	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	5/31/13	United States of America	Urban	32.5|-117.157	not collected	12667.X3004746	MSV000085724_X3004746	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X3008459_RB12_01_55047.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3008459	56	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	9/13/13	United States of America	Urban	32.5|-117.158	not collected	12667.X3008459	MSV000085724_X3008459	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3012989_GB5_01_54910.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3012989	48	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526	12/20/13	United States of America	Urban	32.5|-117.159	not collected	12667.X3012989	MSV000085724_X3012989	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3015659_RA6_01_55024.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3015659	53	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	2/22/14	United States of America	Urban	32.5|-117.160	not collected	12667.X3015659	MSV000085724_X3015659	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3018928_RD1_01_55067.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3018928	53	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	4/22/14	United States of America	Urban	32.5|-117.161	not collected	12667.X3018928	MSV000085724_X3018928	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3019107_GD12_01_54947.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3019107	57	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	5/5/14	United States of America	Urban	32.5|-117.162	not collected	12667.X3019107	MSV000085724_X3019107	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3021397_RD11_01_55078.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3021397	51	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	11/9/14	United States of America	Urban	32.5|-117.163	not collected	12667.X3021397	MSV000085724_X3021397	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3023585_RH11_01_55145.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3023585	20	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	7/25/14	United States of America	Urban	32.5|-117.164	not collected	12667.X3023585	MSV000085724_X3023585	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3023798_RC2_01_55052.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3023798	63	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	7/15/14	United States of America	Urban	32.5|-117.165	not collected	12667.X3023798	MSV000085724_X3023798	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3024195_RE4_01_55088.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3024195	60	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	7/15/14	United States of America	Urban	32.5|-117.166	not collected	12667.X3024195	MSV000085724_X3024195	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3028572_RH2_01_55135.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3028572	24	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	6/8/14	United States of America	Urban	32.5|-117.167	not collected	12667.X3028572	MSV000085724_X3028572	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3030817_GH12_01_55012.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3030817	56	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	9/24/14	United States of America	Urban	32.5|-117.168	not collected	12667.X3030817	MSV000085724_X3030817	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3030973_RB10_01_55045.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3030973	55	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	12/16/14	United States of America	Urban	32.5|-117.169	not collected	12667.X3030973	MSV000085724_X3030973	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X3031283_RG3_01_55119.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3031283	37	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	10/31/14	United States of America	Urban	32.5|-117.170	not collected	12667.X3031283	MSV000085724_X3031283	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3034050_rerun_RH12_01_55175.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3034050	66	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	2/12/14	United States of America	Urban	32.5|-117.171	not collected	12667.X3034050	MSV000085724_X3034050	Later Adulthood (>65 yrs)	UBERON:0001969	no disease reported
MSV000085724	X3034380_RC12_01_55063.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3034380	25	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	11/26/14	United States of America	Urban	32.5|-117.172	not collected	12667.X3034380	MSV000085724_X3034380	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3037415_GA3_01_54893.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3037415	47	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	no disease reported	2/18/15	United States of America	Urban	32.5|-117.173	not collected	12667.X3037415	MSV000085724_X3037415	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3038783_RH9_01_55143.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3038783	63	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	4/17/15	United States of America	Urban	32.5|-117.174	not collected	12667.X3038783	MSV000085724_X3038783	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3039009_RG8_01_55126.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3039009	46	female	blood plasma	not applicable	Healthy	no disease reported	no disease reported	3/23/15	United States of America	Urban	32.5|-117.175	not collected	12667.X3039009	MSV000085724_X3039009	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	no disease reported
MSV000085724	X3039490_GF5_01_54971.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3039490	27	female	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	no disease reported	3/13/15	United States of America	Urban	32.5|-117.176	not collected	12667.X3039490	MSV000085724_X3039490	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3039831_GD4_01_54938.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3039831	66	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526	5/20/15	United States of America	Urban	32.5|-117.177	not collected	12667.X3039831	MSV000085724_X3039831	Later Adulthood (>65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3040432_RA12_01_55031.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3040432	45	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	1/6/15	United States of America	Urban	32.5|-117.178	not collected	12667.X3040432	MSV000085724_X3040432	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3040805_RE11_01_55096.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3040805	51	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	5/19/15	United States of America	Urban	32.5|-117.179	not collected	12667.X3040805	MSV000085724_X3040805	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3042110_GD10_01_54945.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3042110	66	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526	8/7/15	United States of America	Urban	32.5|-117.180	not collected	12667.X3042110	MSV000085724_X3042110	Later Adulthood (>65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3043603_GE6_01_54957.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3043603	50	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526	8/17/15	United States of America	Urban	32.5|-117.181	not collected	12667.X3043603	MSV000085724_X3043603	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3043708_GD9_01_54944.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3043708	58	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526	8/15/15	United States of America	Urban	32.5|-117.182	not collected	12667.X3043708	MSV000085724_X3043708	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3053590_RA5_01_55023.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3053590	48	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	no disease reported	4/11/15	United States of America	Urban	32.5|-117.183	not collected	12667.X3053590	MSV000085724_X3053590	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3054480_RH8_01_55142.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3054480	35	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	11/16/15	United States of America	Urban	32.5|-117.184	not collected	12667.X3054480	MSV000085724_X3054480	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3054832_RA8_01_55027.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3054832	21	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	1/12/15	United States of America	Urban	32.5|-117.185	not collected	12667.X3054832	MSV000085724_X3054832	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	no disease reported
MSV000085724	X3055778_RE6_01_55090.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3055778	59	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	12/15/15	United States of America	Urban	32.5|-117.186	not collected	12667.X3055778	MSV000085724_X3055778	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3056486_RF12_01_55113.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3056486	49	female	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	6/1/16	United States of America	Urban	32.5|-117.187	not collected	12667.X3056486	MSV000085724_X3056486	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X3062186_RH1_01_55134.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3062186	53	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	4/21/16	United States of America	Urban	32.5|-117.188	not collected	12667.X3062186	MSV000085724_X3062186	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3062808_RD7_01_55073.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3062808	44	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	no disease reported	3/30/16	United States of America	Urban	32.5|-117.189	not collected	12667.X3062808	MSV000085724_X3062808	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3064254_GH11_01_55011.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3064254	54	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526	11/4/16	United States of America	Urban	32.5|-117.190	not collected	12667.X3064254	MSV000085724_X3064254	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3064282_RC9_01_55060.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3064282	47	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	4/13/16	United States of America	Urban	32.5|-117.191	not collected	12667.X3064282	MSV000085724_X3064282	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3071967_RF2_01_55102.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3071967	41	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526	7/15/16	United States of America	Urban	32.5|-117.192	not collected	12667.X3071967	MSV000085724_X3071967	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3073917_rerun_GG12_01_55171.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3073917	43	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	10/21/16	United States of America	Urban	32.5|-117.193	not collected	12667.X3073917	MSV000085724_X3073917	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3074050_RG12_01_55130.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3074050	60	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	10/28/16	United States of America	Urban	32.5|-117.194	not collected	12667.X3074050	MSV000085724_X3074050	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3074128_RD8_01_55075.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3074128	39	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	9/15/16	United States of America	Urban	32.5|-117.195	not collected	12667.X3074128	MSV000085724_X3074128	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3074166_RA11_01_55030.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3074166	58	female	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	9/14/16	United States of America	Urban	32.5|-117.196	not collected	12667.X3074166	MSV000085724_X3074166	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X3076646_RC1_01_55051.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3076646	59	female	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	4/11/16	United States of America	Urban	32.5|-117.197	not collected	12667.X3076646	MSV000085724_X3076646	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X3079141_RA4_01_55022.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3079141	37	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	no disease reported	12/13/16	United States of America	Urban	32.5|-117.198	not collected	12667.X3079141	MSV000085724_X3079141	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3081786_RB9_01_55044.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3081786	39	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	1/3/17	United States of America	Urban	32.5|-117.199	not collected	12667.X3081786	MSV000085724_X3081786	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3088501_RA9_01_55028.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3088501	37	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	2/21/15	United States of America	Urban	32.5|-117.200	not collected	12667.X3088501	MSV000085724_X3088501	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3090550_RF4_01_55104.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3090550	38	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	no disease reported	4/19/17	United States of America	Urban	32.5|-117.201	not collected	12667.X3090550	MSV000085724_X3090550	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3090565_RB1_01_55035.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3090565	37	female	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	12/5/17	United States of America	Urban	32.5|-117.202	not collected	12667.X3090565	MSV000085724_X3090565	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3091374_GA12_01_54903.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3091374	51	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526	4/17/17	United States of America	Urban	32.5|-117.203	not collected	12667.X3091374	MSV000085724_X3091374	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3092766_RA10_01_55029.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3092766	36	female	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526	12/5/17	United States of America	Urban	32.5|-117.204	not collected	12667.X3092766	MSV000085724_X3092766	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3093550_RA1_01_55019.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3093550	25	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	no disease reported	5/16/17	United States of America	Urban	32.5|-117.205	not collected	12667.X3093550	MSV000085724_X3093550	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3095232_RC11_01_55062.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3095232	33	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	no disease reported	5/16/17	United States of America	Urban	32.5|-117.206	not collected	12667.X3095232	MSV000085724_X3095232	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3095786_RE9_01_55094.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3095786	34	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	7/6/17	United States of America	Urban	32.5|-117.207	not collected	12667.X3095786	MSV000085724_X3095786	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3095966_rerun_02_GG7_01_55176.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3095966	28	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	6/14/17	United States of America	Urban	32.5|-117.208	not collected	12667.X3095966	MSV000085724_X3095966	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3096081_RF9_01_55110.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3096081	54	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	no disease reported	7/17/17	United States of America	Urban	32.5|-117.209	not collected	12667.X3096081	MSV000085724_X3096081	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3096432_RD9_01_55076.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3096432	56	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	12/6/17	United States of America	Urban	32.5|-117.210	not collected	12667.X3096432	MSV000085724_X3096432	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3097041_RF8_01_55109.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3097041	62	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	no disease reported	7/18/17	United States of America	Urban	32.5|-117.211	not collected	12667.X3097041	MSV000085724_X3097041	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3097210_RG9_01_55127.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3097210	42	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	7/21/17	United States of America	Urban	32.5|-117.212	not collected	12667.X3097210	MSV000085724_X3097210	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3097243_RD6_01_55072.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3097243	40	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	7/31/17	United States of America	Urban	32.5|-117.213	not collected	12667.X3097243	MSV000085724_X3097243	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3099893_rerun_GG9_01_55168.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3099893	35	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	8/16/17	United States of America	Urban	32.5|-117.214	not collected	12667.X3099893	MSV000085724_X3099893	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3106774_rerun_RH7_01_55174.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3106774	57	female	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	2/11/17	United States of America	Urban	32.5|-117.215	not collected	12667.X3106774	MSV000085724_X3106774	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X3109548_RA7_01_55025.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3109548	20	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	no disease reported	8/1/18	United States of America	Urban	32.5|-117.216	not collected	12667.X3109548	MSV000085724_X3109548	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3109592_RE8_01_55093.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3109592	41	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	12/1/18	United States of America	Urban	32.5|-117.217	not collected	12667.X3109592	MSV000085724_X3109592	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3109641_RC5_01_55055.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3109641	42	male	blood plasma	not applicable	Healthy	no disease reported	no disease reported	12/22/17	United States of America	Urban	32.5|-117.218	not collected	12667.X3109641	MSV000085724_X3109641	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	no disease reported
MSV000085724	X3121108_RC8_01_55059.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3121108	57	female	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	7/27/18	United States of America	Urban	32.5|-117.219	not collected	12667.X3121108	MSV000085724_X3121108	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635
MSV000085724	X3122336_RH6_01_55139.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3122336	58	female	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	8/17/18	United States of America	Urban	32.5|-117.220	not collected	12667.X3122336	MSV000085724_X3122336	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X3122400_GH8_01_55008.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3122400	18	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	DOID:1596	8/14/18	United States of America	Urban	32.5|-117.221	not collected	12667.X3122400	MSV000085724_X3122400	Adolescence (8 yrs < x <= 18 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3124209_GA8_01_54898.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3124209	31	male	blood plasma	not applicable	Chronic Illness	human immunodeficiency virus infectious disease	no disease reported	1/10/18	United States of America	Urban	32.5|-117.222	not collected	12667.X3124209	MSV000085724_X3124209	Early Adulthood (18 yrs < x <= 45 yrs)	UBERON:0001969	DOID:526
MSV000085724	X3124859_RE7_01_55092.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3124859	63	male	blood plasma	not applicable	Chronic Illness	mental depression	no disease reported	11/30/18	United States of America	Urban	32.5|-117.223	not collected	12667.X3124859	MSV000085724_X3124859	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:1596
MSV000085724	X3130165_rerun_GA2_01_55152.mzXML	animal	biofluid	9606|Homo sapiens	2020	blood NOS	ethanol-water (9:1)	sulfamethazine;sulfadimethoxine	impact HD|MS:1002667	electrospray ionization (positive)	reverse phase (C18)	X3130165	57	male	blood plasma	not applicable	Chronic Illness	acquired immunodeficiency syndrome	DOID:526|DOID:1596	3/1/19	United States of America	Urban	32.5|-117.224	not collected	12667.X3130165	MSV000085724_X3130165	Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969	DOID:635